Gagnon Advisors, LLC
13F Reported Value
ⓘ$157.3M
Holdings
23
Latest Filing
2026-06-30
Filing Quarter
Q2 2026
Portfolio Overview
Gagnon Advisors, LLC disclosed 23 positions worth $157.3M in its Form 13F-HR for Q2 2026, led by $CDNA (CareDx, Inc.) at 9.9% of the equity portfolio, followed by $AMRC and $EPD. During the quarter the fund opened 4 new positions and exited 3 — including a new stake in $NOV and a full exit from $NVGS. The portfolio is most concentrated in Healthcare (42.4% of disclosed assets). All figures are sourced directly from Gagnon Advisors, LLC’s Form 13F-HR filing with the SEC under CIK 1599466.
AI Fund Analysis
DiversifyingSector Allocation
AUM History
Top Equity Holdings by Value
Quarterly Activity — Q2 2026
Click any card to unlockTop Holdings
- 67.5#361
Quality
$15.6M546,893 sh - 42.9#1,988
Quality
$13.0M472,798 sh - 61.4#780
Quality
$12.5M339,877 sh - 35.4
Quality
$12.2M177,870 sh - 59.0
Quality
$11.2M10,715 sh - 74.9
Quality
$9.4M113,304 sh - 51.5
Quality
$8.9M352,637 sh - 68.6
Quality
$7.9M776,212 sh - 62.1
Quality
$7.7M274,217 sh - 59.7
Quality
$7.2M336,277 sh
| Company | Quality | Value | Shares |
|---|---|---|---|
 CareDx, Inc.$CDNA | 67.5#361 | $15.6M | 546,893 |
 Ameresco, Inc.$AMRC | 42.9#1,988 | $13.0M | 472,798 |
 ENTERPRISE PRODUCTS PARTNERS L.P.$EPD | 61.4#780 | $12.5M | 339,877 |
 GeneDx Holdings Corp.$WGS | 35.4 | $12.2M | 177,870 |
 EQUINIX INC$EQIX | 59.0 | $11.2M | 10,715 |
 Hinge Health, Inc.$HNGE | 74.9 | $9.4M | 113,304 |
 Pacira BioSciences, Inc.$PCRX | 51.5 | $8.9M | 352,637 |
 Freshworks Inc.$FRSH | 68.6 | $7.9M | 776,212 |
 BIOLIFE SOLUTIONS INC$BLFS | 62.1 | $7.7M | 274,217 |
 Five9, Inc.$FIVN | 59.7 | $7.2M | 336,277 |
Unlock AI quality scores for every holding
32-signal composite ranking on each of Gagnon Advisors, LLC's 23 positions.
Showing top 10 of 23 holdings.
Sector Allocation
Healthcare
$66.6M
Technology
$43.7M
Energy
$18.6M
Industrials
$13.0M
Real Estate
$11.2M
Consumer Discretionary
$3.6M
Financials
$299,207
Consumer Staples
$291,660
Full Holdings — Gagnon Advisors, LLC (Q2 2026)
All 23 disclosed positions from the latest Form 13F-HR, with quarter-over-quarter share changes and 13F Pro quality scores. Sourced from SEC EDGAR.
| # | Ticker | Company | Value | Weight | QoQ | Quality |
|---|---|---|---|---|---|---|
| 1 | $CDNA | CareDx, Inc. | $15.6M | 9.9% | +3% | 67.5 |
| 2 | $AMRC | Ameresco, Inc. | $13.0M | 8.3% | +0% | 42.9 |
| 3 | $EPD | ENTERPRISE PRODUCTS PARTNERS L.P. | $12.5M | 7.9% | +0% | 61.4 |
| 4 | $WGS | GeneDx Holdings Corp. | $12.2M | 7.8% | +20% | 35.4 |
| 5 | $EQIX | EQUINIX INC | $11.2M | 7.1% | +0% | 59 |
| 6 | $HNGE | Hinge Health, Inc. | $9.4M | 6.0% | +40% | 74.9 |
| 7 | $PCRX | Pacira BioSciences, Inc. | $8.9M | 5.7% | +0% | 51.5 |
| 8 | $FRSH | Freshworks Inc. | $7.9M | 5.0% | +0% | 68.6 |
| 9 | $BLFS | BIOLIFE SOLUTIONS INC | $7.7M | 4.9% | +0% | 62.1 |
| 10 | $FIVN | Five9, Inc. | $7.2M | 4.6% | +0% | 59.7 |
| 11 |  $PROF | Profound Medical Corp. | $6.4M | 4.1% | +0% | — |
| 12 |  $NOV | NOV Inc. | $6.1M | 3.9% | NEW | 47.8 |
| 13 |  $TMCI | TREACE MEDICAL CONCEPTS, INC. | $6.1M | 3.9% | NEW | 25.6 |
| 14 |  $OSUR | ORASURE TECHNOLOGIES INC | $5.4M | 3.4% | +0% | 12.6 |
| 15 |  $AMPL | Amplitude, Inc. | $4.9M | 3.1% | +0% | 35.4 |
| 16 |  $DV | DoubleVerify Holdings, Inc. | $4.7M | 3.0% | +0% | 61.6 |
| 17 |  $QDEL | QuidelOrtho Corp | $4.2M | 2.7% | NEW | 28.2 |
| 18 |  $VERX | Vertex, Inc. | $4.2M | 2.6% | +22% | 57.5 |
| 19 |  $BL | BLACKLINE, INC. | $3.7M | 2.3% | +0% | 52.7 |
| 20 |  $HZO | MARINEMAX INC | $3.6M | 2.3% | +0% | 42.4 |
| 21 |  $KLTR | KALTURA INC | $1.8M | 1.2% | +0% | 31.2 |
| 22 |  $CNF | CNFinance Holdings Ltd. | $299,207 | 0.2% | +34% | — |
| 23 |  $BYND | BEYOND MEAT, INC. | $291,660 | 0.2% | NEW | 38.4 |
New Positions (4)
Browse Top Institutional Investors
13F Pro tracks 8,700+ institutional investors filing 13F reports with the SEC.
to search all 8,700+ institutional filers.
Available Analysis
13F Pro tracks comprehensive institutional data for Gagnon Advisors, LLC including:
Track Gagnon Advisors, LLC's Full Portfolio
See every holding, quarter-over-quarter changes, sector allocation, and accumulation patterns for Gagnon Advisors, LLC and 8,700+ other institutional investors.
Free tier includes full 13F search and fund profiles. Pro starts at $6.67/mo (billed annually).
AI-Powered Hedge Fund Analysis: Gagnon Advisors, LLC
13F Pro is an AI hedge fund tracker and stock research platform. For Gagnon Advisors, LLC (SEC CIK: 1599466), the platform ingests every quarterly Form 13F filing and applies AI-powered analysis on top — 10 specialized AI analysts (value, growth, momentum, macro, activist, and more) debate the fund's top positions and publish AI-generated analysis with cited SEC sources.
Every holding in Gagnon Advisors, LLC's portfolio is scored on a 32-signal AI quality ranking (ROIC, FCF margin, revenue growth, institutional flow, earnings quality, shareholder dilution, and more). Track accumulation and distribution quarter over quarter, identify conviction positions, and see AI stock analysis for each position — alongside 8,700+ other institutional filers and 2,800+ AI-ranked companies.